Orphan Drugs

(asked on 21st February 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that NHS England and NICE revise their appraisal criteria for the NICE Highly Specialised Technologies as a result of the Scottish Medicines Consortium’s review of the definition of orphan and ultra-orphan designation route to include condition prevalence criteria; and if he will ensure that they publish those prevalence criteria.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 1st March 2018

The Government and the National Institute for Health and Care Excellence (NICE) have no plans to review the criteria for the selection of topics for referral to NICE’s Highly Specialised Technologies (HST) programme. The topic selection criteria for HST are published at:

https://www.nice.org.uk/about/what-we-do/our-programmes/topic-selection

Reticulating Splines